"不眠症"を公衆衛生の課題に優先させる必要性: 睡眠と精神衛生の欧州とカナダの専門家による"目覚め声"の立場書
Laura Palagini1, Celso Arango2, Claudio Lino Alberto Bassetti3
1Department of Neuroscience, Psychiatric Section, University of Pisa, Azienda Ospedaliera Universitaria Pisana (AUOP), Pisa, Italy.
Sleep medicine
|August 31, 2025
まとめ
慢性的な不眠症は公衆衛生に重大な影響を及ぼしますが 認知と一貫した治療のサポートが欠けているのです 専門家は公衆衛生システムに この状態を優先し 証拠に基づいた治療を メンタルヘルスモデルに組み込むよう促しています
科学分野:
- 睡眠医学
- 精神 的 な 健康
- 公衆衛生政策
背景:
- 不眠症は,ヨーロッパとカナダで流行する慢性的な精神疾患です.
- 現在の医療制度では 慢性的な不眠症を 障害として認識できず 患者のケアやサポートが不十分です
研究 の 目的:
- 慢性的な不眠症を認識する 公共衛生システムの必要性を強調します
- 不眠症の患者を支援し,一貫したケアを提供することを主張する.
主な方法:
- 睡眠と精神衛生の専門家からなるコンソーシアムが ポジション・ペーパーを作成しました
- 不眠症の流行病学,経済/健康上の課題,医療制度の枠組みに関する記述的レビューが行われました.
主要な成果:
- 不眠症は公衆衛生上の大きな問題ですが 当局では十分に認識されず 優先順位が下がっています
- この認識の欠如は 推奨される不眠治療の 払い戻しや資金援助の欠如につながります
結論:
- 不眠症の重荷を悪化させています
- 公共衛生システムは 患者の支援を優先し 慢性的な不眠症の治療を 段階的なケアモデルに統合しなければなりません
関連する概念動画
Insomnia
124
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
124
Insufficient Sleep and Sleep Deprivation
210
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
210
Management of Insomnia
320
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
320
Substance Use Disorders Affecting Sleep
216
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
216
CNS Depressants: Barbiturates and Benzodiazepines
466
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
466
Sedatives and Hypnotics Drugs: Miscellaneous Agents
238
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
238


